AAAAAA
Results:
1-13
|
Results: 13
Authors:
Benhamou, Y
Di Martino, V
Bochet, M
Colombet, G
Thibault, V
Liou, A
Katlama, C
Poynard, T
Citation: Y. Benhamou et al., Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy, HEPATOLOGY, 34(2), 2001, pp. 283-287
Authors:
Poynard, T
Regimbeau, C
Benhamou, Y
Citation: T. Poynard et al., Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, ALIM PHARM, 15(3), 2001, pp. 355-361
Authors:
Benhamou, Y
Bochet, M
Thibault, V
Calvez, V
Fievet, MH
Vig, P
Gibbs, CS
Brosgart, C
Fry, J
Namini, H
Katiama, C
Poynard, T
Citation: Y. Benhamou et al., Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study, LANCET, 358(9283), 2001, pp. 718-723
Authors:
Imbert-Bismut, F
Ratziu, V
Pieroni, L
Charlotte, F
Benhamou, Y
Poynard, T
Citation: F. Imbert-bismut et al., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, LANCET, 357(9262), 2001, pp. 1069-1075
Authors:
Poynard, T
Ratziu, V
Benhamou, Y
Opolon, P
Cacoub, P
Bedossa, P
Citation: T. Poynard et al., Natural history of HCV infection, BEST PR RES, 14(2), 2000, pp. 211-228
Authors:
Cacoub, P
Sbai, A
Benhamou, Y
Godeau, P
Piette, JC
Citation: P. Cacoub et al., Recurrent severe gastrointestinal hemorrhage complicating diffuse angiodysplasia: efficacy of estrogen and progesterone therapy, PRESSE MED, 29(3), 2000, pp. 139-141
Authors:
Allory, Y
Charlotte, F
Benhamou, Y
Opolon, P
Le Charpentier, Y
Poynard, T
Citation: Y. Allory et al., Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: A case-control study, HUMAN PATH, 31(1), 2000, pp. 69-74
Authors:
Zylberberg, H
Benhamou, Y
Lagneaux, JL
Landau, A
Chaix, ML
Fontaine, H
Bochet, M
Poynard, T
Katlama, C
Pialoux, G
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIVcoinfected subjects: an early report, GUT, 47(5), 2000, pp. 694-697
Authors:
Benhamou, Y
Bochet, M
Thibault, V
Di Martino, V
Caumes, E
Bricaire, F
Opolon, P
Katlama, C
Poynard, T
Citation: Y. Benhamou et al., Long-term incidence of hepatitis B virus resistance to lamivudine in humanimmunodeficiency virus-infected patients, HEPATOLOGY, 30(5), 1999, pp. 1302-1306
Authors:
Benhamou, Y
Bochet, M
Di Martino, V
Charlotte, F
Azria, F
Coutellier, A
Vidaud, M
Bricaire, F
Opolon, P
Katlama, C
Poynard, T
Citation: Y. Benhamou et al., Liver fibrosis progression in human immunodeficiency virus and hepatitis Cvirus coinfected patients, HEPATOLOGY, 30(4), 1999, pp. 1054-1058
Authors:
Di Martino, V
Ezenfis, J
Benhamou, Y
Bernard, B
Opolon, P
Bricaire, F
Poynard, T
Citation: V. Di Martino et al., Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge, AIDS, 13(11), 1999, pp. 1421-1423
Authors:
Thibault, V
Benhamou, Y
Seguret, C
Bochet, M
Katlama, C
Bricaire, F
Opolon, P
Poynard, T
Agut, H
Citation: V. Thibault et al., Hepatitis B virus (HBV) mutations associated with resistance to lamivudinein patients coinfected with HBV and human immunodeficiency virus, J CLIN MICR, 37(9), 1999, pp. 3013-3016
Authors:
Capet, C
Kapel, N
Huneau, JF
Magne, D
Laikuen, R
Tricottet, V
Benhamou, Y
Tome, D
Gobert, JG
Citation: C. Capet et al., Cryptosporidium parvum infection in suckling rats: Impairment of mucosal permeability and Na+-glucose cotransport, EXP PARASIT, 91(2), 1999, pp. 119-125
Risultati:
1-13
|